Literature DB >> 25099448

The role of bridge therapy prior to orthotopic liver transplantation.

Meena A Prasad1, Laura M Kulik1.   

Abstract

Orthotopic liver transplantation (OLT) offers the best chance for cure in the setting of unresectable hepatocellular carcinoma (HCC). A consensus statement recommends locoregional therapy (LRT) be considered in patients with HCC who are expected to wait more than 6 months for OLT to diminish dropout from the waiting list because of tumor progression. This article reviews LRT as a bridge to OLT in patients with HCC.
Copyright © 2014 by the National Comprehensive Cancer Network.

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25099448     DOI： 10.6004/jnccn.2014.0113

Source DB:  PubMed          Journal:  J Natl Compr Canc Netw        ISSN： 1540-1405            Impact factor:   11.908


  8 in total

1.  Efficacy of contrast-enhanced FDG PET/CT in patients awaiting liver transplantation with rising alpha-fetoprotein after bridge therapy of hepatocellular carcinoma.

Authors:  Rania Refaat; Mohammad Abd Alkhalik Basha; Mohammed Sobhi Hassan; Rasha S Hussein; Ahmed A El Sammak; Dena Abd El Aziz El Sammak; Mohamed Hesham Saleh Radwan; Nahla M Awad; Somaia A Saad El-Din; Engi Elkholy; Dina R D Ibrahim; Shereen A Saleh; Iman F Montasser; Hany Said
Journal:  Eur Radiol       Date:  2018-06-12       Impact factor: 5.315

Review 2.  HCC-Associated Liver Transplantation - Where Are the Limits and What Are the New Regulations?

Authors:  Christian P Strassburg
Journal:  Visc Med       Date:  2016-06-20

Review 3.  Imaging of hepatocellular carcinoma and image guided therapies - how we do it.

Authors:  Jonathon Willatt; Julie A Ruma; Shadi F Azar; Nara L Dasika; F Syed
Journal:  Cancer Imaging       Date:  2017-03-04       Impact factor: 3.909

4.  Efficacy of loco-regional treatment for hepatocellular carcinoma prior to living donor liver transplantation: a report from a single center in Egypt.

Authors:  Mohammad Kamal Shaker; Iman F Montasser; Mohamed Sakr; Mohamed Elgharib; Hany M Dabbous; Hend Ebada; Ahmed El Dorry; Mohamed Bahaa; Mahmoud El Meteini
Journal:  J Hepatocell Carcinoma       Date:  2018-02-27

5.  Bridging Therapies With Injectable Immunomodulatory Drugs in the Management of Multiple Sclerosis: A Delphi Survey of an Italian Expert Panel of Neurologists.

Authors:  Girolama Alessandra Marfia; Diego Centonze; Marco Salvetti; Elisabetta Ferraro; Valentina Panetta; Claudio Gasperini; Massimiliano Mirabella; Antonella Conte
Journal:  Front Neurol       Date:  2022-07-15       Impact factor: 4.086

6.  Pretransplant Locoregional Therapy for Hepatocellular Carcinoma: Evaluation of Explant Pathology and Overall Survival.

Authors:  Eliza W Beal; Kristin M Dittmar; A James Hanje; Anthony J Michaels; Lanla Conteh; Gail Davidson; Sylvester M Black; P Mark Bloomston; Mary E Dillhoff; Carl R Schmidt
Journal:  Front Oncol       Date:  2016-06-13       Impact factor: 6.244

Review 7.  The role of 90Y-radioembolization in downstaging primary and secondary hepatic malignancies: a systematic review.

Authors:  M N G J A Braat; M Samim; M A A J van den Bosch; M G E H Lam
Journal:  Clin Transl Imaging       Date:  2016-04-23

Review 8.  Hepatocellular carcinoma: early-stage management challenges.

Authors:  Derek J Erstad; Kenneth K Tanabe
Journal:  J Hepatocell Carcinoma       Date:  2017-06-23
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.